John R. Su

8.7k total citations · 6 hit papers
64 papers, 4.6k citations indexed

About

John R. Su is a scholar working on Infectious Diseases, Health and Epidemiology. According to data from OpenAlex, John R. Su has authored 64 papers receiving a total of 4.6k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Infectious Diseases, 22 papers in Health and 18 papers in Epidemiology. Recurrent topics in John R. Su's work include SARS-CoV-2 and COVID-19 Research (22 papers), Vaccine Coverage and Hesitancy (22 papers) and Syphilis Diagnosis and Treatment (13 papers). John R. Su is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (22 papers), Vaccine Coverage and Hesitancy (22 papers) and Syphilis Diagnosis and Treatment (13 papers). John R. Su collaborates with scholars based in United States, Uganda and Kenya. John R. Su's co-authors include Hillard Weinstock, Tom T. Shimabukuro, Elizabeth Torrone, Paige Marquez, Julianne Gee, Reena Mahajan, Eileen F. Dunne, Elissa Meites, Catherine L. Satterwhite and Fujie Xu and has published in prestigious journals such as JAMA, Annals of Internal Medicine and PLoS ONE.

In The Last Decade

John R. Su

64 papers receiving 4.4k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Sexually Transmitted Infections Among US Women and Men

2013 1.0k citations Catherine L. Satterwhite, Elizabeth Torrone et al. Sexually Transmitted Diseases profile →
Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices — United States, June 2021

2021 371 citations John R. Su, Karen R. Broder et al. MMWR Morbidity and Mortality Weekly Report profile →
Reports of Anaphylaxis After Receipt of mRNA COVID-19 Vaccines in the US—December 14, 2020-January 18, 2021

2021 289 citations Tom T. Shimabukuro, John R. Su et al. profile →
First Month of COVID-19 Vaccine Safety Monitoring — United States, December 14, 2020–January 13, 2021

2021 275 citations Julianne Gee, Paige Marquez et al. MMWR Morbidity and Mortality Weekly Report profile →
Updated Recommendations from the Advisory Committee on Immunization Practices for Use of the Janssen (Johnson & Johnson) COVID-19 Vaccine After Reports of Thrombosis with Thrombocytopenia Syndrome Among Vaccine Recipients — United States, April 2021

2021 130 citations John R. Su, Karen R. Broder et al. MMWR Morbidity and Mortality Weekly Report profile →
Safety of mRNA vaccines administered during the initial 6 months of the US COVID-19 vaccination programme: an observational study of reports to the Vaccine Adverse Event Reporting System and v-safe

2022 116 citations Julianne Gee, Paige Marquez et al. profile →

Peers

Countries citing papers authored by John R. Su

Since Specialization

Citations

This map shows the geographic impact of John R. Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John R. Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John R. Su more than expected).

Fields of papers citing papers by John R. Su

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John R. Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John R. Su. The network helps show where John R. Su may publish in the future.

Co-authorship network of co-authors of John R. Su

This figure shows the co-authorship network connecting the top 25 collaborators of John R. Su. A scholar is included among the top collaborators of John R. Su based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John R. Su. John R. Su is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Tinnitus after COVID-19 vaccination: Findings from the vaccine adverse event reporting system and the vaccine safety datalink 2024 ·American Journal of Otolaryngology ·W. Katherine Yih, Jonathan Duffy, John R. Su, (unknown), Bruce Fireman, Laura P. Hurley, Judith C. Maro, Paige Marquez, Pedro L. Moro, Narayan Nair, Jennifer C. Nelson, Ning Smith, Maria E. Sundaram, (unknown), Eric Weintraub, Stanley Xu, Tom T. Shimabukuro	1
2	Post-authorization safety surveillance of Ad.26.COV2.S vaccine: Reports to the Vaccine Adverse Event Reporting System and v-safe, February 2021–February 2022 2023 ·Vaccine ·Emily Jane Woo, Julianne Gee, Paige Marquez, James Baggs, Winston E. Abara, Michael M. McNeil, Rositsa B. Dimova, John R. Su	8
3	Safety Monitoring of Bivalent COVID-19 mRNA Vaccine Booster Doses Among Children Aged 5–11 Years — United States, October 12–January 1, 2023 2023 ·MMWR Morbidity and Mortality Weekly Report ·Anne M. Hause, Paige Marquez, Bicheng Zhang, John R. Su, Tanya R. Myers, Julianne Gee, S. Panchanathan, Deborah Thompson, Tom T. Shimabukuro, David K. Shay	23
4	Notes from the Field: Safety Monitoring of Novavax COVID-19 Vaccine Among Persons Aged ≥12 Years — United States, July 13, 2022–March 13, 2023 2023 ·MMWR Morbidity and Mortality Weekly Report ·(unknown), Pedro L. Moro, John R. Su, Paige Marquez, Narayan Nair, (unknown), (unknown), Tom T. Shimabukuro	2
5	Reports of Guillain-Barré Syndrome After COVID-19 Vaccination in the United States 2023 ·JAMA Network Open ·Winston E. Abara, Julianne Gee, Paige Marquez, (unknown), Tanya R. Myers, (unknown), Jane Baumblatt, Emily Jane Woo, Deborah Thompson, Narayan Nair, John R. Su, Tom T. Shimabukuro, David K. Shay	41
6	Safety of co-administration of mRNA COVID-19 and seasonal inactivated influenza vaccines in the vaccine adverse event reporting system (VAERS) during July 1, 2021–June 30, 2022 2023 ·Vaccine ·Pedro L. Moro, Bicheng Zhang, (unknown), Margaret Harris, (unknown), Gina Woody, Paige Marquez, Michael M. McNeil, John R. Su	18
7	Reporting rates for VAERS death reports following COVID ‐19 vaccination, December 14, 2020–November 17, 2021 2023 ·Pharmacoepidemiology and Drug Safety ·(unknown), David Menschik, Deborah Thompson, Christopher Jankosky, John R. Su, Pedro L. Moro, Craig Zinderman, Kerry J. Welsh, Rositsa B. Dimova, Narayan Nair	1
8	Safety surveillance of meningococcal group B vaccine (Bexsero®), Vaccine Adverse Event Reporting System, 2015–2018 2021 ·Vaccine ·Silvia Pérez-Vilar, Graça M. Dores, Paige Marquez, Carmen S. Ng, Maria Cano, (unknown), Lucia Lee, John R. Su, Jonathan Duffy	6
9	Myopericarditis after vaccination, Vaccine Adverse Event Reporting System (VAERS), 1990–2018 2021 ·Vaccine ·John R. Su, Michael M. McNeil, Kerry J. Welsh, Paige Marquez, Carmen S. Ng, Ming Yan, Maria Cano	113
10	U.S. Population-Based background incidence rates of medical conditions for use in safety assessment of COVID-19 vaccines 2021 ·Vaccine ·Diane M. Gubernot, Amelia Jazwa, Manette T. Niu, Jane Baumblatt, Julianne Gee, Pedro L. Moro, Jonathan Duffy, Theresa Harrington, Michael M. McNeil, Karen R. Broder, John R. Su, Satoshi Kamidani, Christine K. Olson, Lakshmi Panagiotakopoulos, Tom T. Shimabukuro, Richard A. Forshee, Steven A. Anderson, Sarah D. Bennett	47
11	The reporting sensitivity of the Vaccine Adverse Event Reporting System (VAERS) for anaphylaxis and for Guillain-Barré syndrome 2020 ·Vaccine ·Elaine R. Miller, Michael M. McNeil, Pedro L. Moro, Jonathan Duffy, John R. Su	26
12	Erythema multiforme, Stevens Johnson syndrome, and toxic epidermal necrolysis reported after vaccination, 1999–2017 2019 ·Vaccine ·John R. Su, Penina Haber, Carmen S. Ng, Paige Marquez, Graça M. Dores, Silvia Pérez-Vilar, Maria Cano	32
13	Anaphylaxis after vaccination reported to the Vaccine Adverse Event Reporting System, 1990-2016 2019 ·Journal of Allergy and Clinical Immunology ·John R. Su, Pedro L. Moro, Carmen S. Ng, (unknown), Maria Said, Maria Cano	74
14	Adverse events after vaccination among HIV-positive persons, 1990–2016 2018 ·PLoS ONE ·John R. Su, Carmen S. Ng, (unknown), Maria Cano	11
15	Co-Infection with Human Immunodeficiency Virus (HIV) Among Individuals with Early Syphilis, By Stage of Syphilitic Infection, 17 Areas — U.S., 2009–2012 2014 ·John R. Su	1
16	Sexually Transmitted Infections Among US Women and Men breakdown → 2013 ·Sexually Transmitted Diseases ·Catherine L. Satterwhite, Elizabeth Torrone, Elissa Meites, Eileen F. Dunne, Reena Mahajan, M. Cheryl Bañez Ocfemia, John R. Su, Fujie Xu, Hillard Weinstock	1005
17	Do Women With Persistently Negative Nontreponemal Test Results Transmit Syphilis During Pregnancy? 2013 ·Sexually Transmitted Diseases ·Thomas A. Peterman, Daniel R. Newman, (unknown), John R. Su	24
18	Epidemiology of Syphilis Among Hispanic Women and Associations With Congenital Syphilis, Maricopa County, Arizona 2011 ·Sexually Transmitted Diseases ·Robert D. Kirkcaldy, John R. Su, Melanie Taylor, Emilia H. Koumans, (unknown), (unknown), (unknown), Hillard Weinstock	16
19	Epidemiologic Investigation of a 2007 Outbreak of Serratia marcescens Bloodstream Infection in Texas Caused by Contamination of Syringes Prefilled With Heparin and Saline 2009 ·Infection Control and Hospital Epidemiology ·John R. Su, David B. Blossom, Wendy Chung, Jessica Smartt Gullion, (unknown), (unknown), Arjun Srinivasan	10
20	Pseudomonas aeruginosa inhibits endocytic recycling of CFTR in polarized human airway epithelial cells 2005 ·American Journal of Physiology-Cell Physiology ·Agnieszka Swiatecka‐Urban, Sophie Moreau‐Marquis, Daniel P. MacEachran, John P. Connolly, (unknown), John R. Su, Roxanna Barnaby, George A. O’Toole, Bruce A. Stanton	62

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact